Alpha beta-crystallin expression and presentation following infection with murine gammaherpesvirus 68

References

• Van Montfort, R., C. Slingsby, and E. Vierling. 2001. Structure and function of the small heat shock protein/alpha-crystallin family of molecular chaperones. Adv Protein Chem. 59: 105–156
   PubMedGoogle Scholar
• Dubin, R. A., E. F. Wawrousek, and J. Piatigorsky. 1989. Expression of the murine alpha B-crystallin gene is not restricted to the lens. Mol Cell Biol. 9: 1083–1091
   PubMed Web of Science ®Google Scholar
• Kase, S., S. He, S. Sonoda, M. Kitamura, C. Spee, E. Wawrousek, S. J. Ryan, et al. 2010. alphaB-crystallin regulation of angiogenesis by modulation of VEGF. Blood. 115: 3398–3406
   PubMed Web of Science ®Google Scholar
• Liu, S., and J. Piatigorsky. 2011. Regulation of mouse small heat shock protein alphab-crystallin gene by aryl hydrocarbon receptor. PLoS One. 6: e17904
   Web of Science ®Google Scholar
• Piao, C. S., S. W. Kim, J. B. Kim, and J. K. Lee. 2005. Co-induction of alphaB-crystallin and MAPKAPK-2 in astrocytes in the penumbra after transient focal cerebral ischemia. Exp Brain Res. 163: 421–429
   PubMed Web of Science ®Google Scholar
• Zhang, M., Y. Lv, Z. Yue, A. Islam, B. Rehana, E. Bao, and J. Hartung. 2011. Effects of transportation on expression of Hsp90, Hsp70, Hsp27 and alphaB-crystallin in the pig stomach. Vet Rec. 169: 312
   PubMed Web of Science ®Google Scholar
• Arac, A., S. E. Brownell, J. B. Rothbard, C. Chen, R. M. Ko, M. P. Pereira, G. W. Albers, et al. 2011. Systemic augmentation of alphaB-crystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation. Proc Natl Acad Sci USA. 108: 13287–13292
   PubMed Web of Science ®Google Scholar
• Klopstein, A., E. Santos-Nogueira, I. Francos-Quijorna, A. Redensek, S. David, X. Navarro, and R. Lopez-Vales. 2012. Beneficial effects of alphaB-crystallin in spinal cord contusion injury. J Neurosci. 32: 14478–14488
   PubMed Web of Science ®Google Scholar
• Ousman, S. S., B. H. Tomooka, J. M. van Noort, E. F. Wawrousek, K. C. O'Connor, D. A. Hafler, R. A. Sobel, et al. 2007. Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination. Nature. 448: 474–479
   PubMed Web of Science ®Google Scholar
• Rothbard, J. B., M. P. Kurnellas, S. Brownell, C. M. Adams, L. Su, R. C. Axtell, R. Chen, et al. 2012. Therapeutic effects of systemic administration of chaperone alphaB-crystallin associated with binding proinflammatory plasma proteins. J Biol Chem. 287: 9708–9721
   PubMed Web of Science ®Google Scholar
• Kurnellas, M. P., S. E. Brownell, L. Su, A. V. Malkovskiy, J. Rajadas, G. Dolganov, S. Chopra, et al. 2012. Chaperone activity of small heat shock proteins underlies therapeutic efficacy in experimental autoimmune encephalomyelitis. J Biol Chem. 287: 36423–36434
   PubMed Web of Science ®Google Scholar
• Rothbard, J. B., X. Zhao, O. Sharpe, M. J. Strohman, M. Kurnellas, E. D. Mellins, W. H. Robinson, and L. Steinman. 2011. Chaperone activity of alpha B-crystallin is responsible for its incorrect assignment as an autoantigen in multiple sclerosis. J Immunol. 186: 4263–4268
   PubMed Web of Science ®Google Scholar
• Steinman, L. 2009. A molecular trio in relapse and remission in multiple sclerosis. Nat Rev Immunol. 9: 440–447
   PubMed Web of Science ®Google Scholar
• van Noort, J. M., M. Bsibsi, W. H. Gerritsen, P. van der Valk, J. J. Bajramovic, L. Steinman, and S. Amor. 2010. Alphab-crystallin is a target for adaptive immune responses and a trigger of innate responses in preactive multiple sclerosis lesions. J Neuropathol Exp Neurol. 69: 694–703
   PubMed Web of Science ®Google Scholar
• van Noort, J. M., M. Bsibsi, P. Nacken, W. H. Gerritsen, and S. Amor. 2012. The link between small heat shock proteins and the immune system. Int J Biochem Cell Biol. 44: 1670–1679
   PubMed Web of Science ®Google Scholar
• Bajramovic, J. J., A. C. Plomp, A. Goes, C. Koevoets, J. Newcombe, M. L. Cuzner, and J. M. van Noort. 2000. Presentation of alpha B-crystallin to T cells in active multiple sclerosis lesions: an early event following inflammatory demyelination. J Immunol. 164: 4359–4366
   PubMed Web of Science ®Google Scholar
• van Noort, J. M., A. C. van Sechel, J. J. Bajramovic, M. el Ouagmiri, C. H. Polman, H. Lassmann, and R. Ravid. 1995. The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis. Nature. 375: 798–801
   PubMed Web of Science ®Google Scholar
• van Noort, J. M., R. Verbeek, J. F. Meilof, C. H. Polman, and S. Amor. 2006. Autoantibodies against alpha B-crystallin, a candidate autoantigen in multiple sclerosis, are part of a normal human immune repertoire. Mult Scler. 12: 287–293
   PubMed Web of Science ®Google Scholar
• Thoua, N. M., J. M. van Noort, D. Baker, A. Bose, A. C. van Sechel, M. J. van Stipdonk, P. J. Travers, and S. Amor. 2000. Encephalitogenic and immunogenic potential of the stress protein alphaB-crystallin in Biozzi ABH (H-2A(g7)) mice. J Neuroimmunol. 104: 47–57
   PubMed Web of Science ®Google Scholar
• van Stipdonk, M. J., A. A. Willems, R. Verbeek, C. J. Boog, and J. M. van Noort. 2000. T- and B-cell nonresponsiveness to self-alphaB-crystallin in SJL mice prevents the induction of experimental allergic encephalomyelitis. Cell Immunol. 204: 128–134
   PubMed Web of Science ®Google Scholar
• Wang, C., Y. K. Chou, C. M. Rich, J. M. Link, M. E. Afentoulis, J. M. van Noort, E. F. Wawrousek, et al. 2006. AlphaB-crystallin-reactive T cells from knockout mice are not encephalitogenic. J Neuroimmunol. 176: 51–62
   PubMed Web of Science ®Google Scholar
• Ransohoff, R. M. 2007. Inflammatory disease: assault on the guardian. Nature. 448: 421–422
   PubMed Web of Science ®Google Scholar
• van Sechel, A. C., J. J. Bajramovic, M. J. van Stipdonk, C. Persoon-Deen, S. B. Geutskens, and J. M. van Noort. 1999. EBV-induced expression and HLA-DR-restricted presentation by human B cells of alpha B-crystallin, a candidate autoantigen in multiple sclerosis. J Immunol. 162: 129–135
   PubMed Web of Science ®Google Scholar
• Barton, E., P. Mandal, and S. H. Speck. 2011. Pathogenesis and host control of gammaherpesviruses: lessons from the mouse. Annu Rev Immunol. 29: 351–397
   PubMed Web of Science ®Google Scholar
• Doherty, P. C., R. A. Tripp, A. M. Hamilton-Easton, R. D. Cardin, D. L. Woodland, and M. A. Blackman. 1997. Tuning into immunological dissonance: an experimental model for infectious mononucleosis. Curr Opin Immunol. 9: 477-483
   PubMed Web of Science ®Google Scholar
• Rajcani, J., and M. Kudelova. 2005. Murine herpesvirus pathogenesis: a model for the analysis of molecular mechanisms of human gamma herpesvirus infections. Acta Microbiol Immunol Hung. 52: 41–71
   PubMedGoogle Scholar
• Sunil-Chandra, N. P., S. Efstathiou, J. Arno, and A. A. Nash. 1992. Virological and pathological features of mice infected with murine gamma-herpesvirus 68. J Gen Virol. 73: 2347–2356
   PubMed Web of Science ®Google Scholar
• Cardin, R. D., J. W. Brooks, S. R. Sarawar, and P. C. Doherty. 1996. Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells. J Exp Med. 184: 863–871
   PubMed Web of Science ®Google Scholar
• Sunil-Chandra, N. P., S. Efstathiou, and A. A. Nash. 1992. Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J Gen Virol. 73: 3275–3279
   PubMed Web of Science ®Google Scholar
• Usherwood, E. J., J. P. Stewart, and A. A. Nash. 1996. Characterization of tumor cell lines derived from murine gammaherpesvirus-68-infected mice. J Virol. 70: 6516–6518
   PubMed Web of Science ®Google Scholar
• Weck, K. E., S. S. Kim, H. I. Virgin, and S. H. Speck. 1999. Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J Virol. 73: 3273–3283
   PubMed Web of Science ®Google Scholar
• Flano, E., S. M. Husain, J. T. Sample, D. L. Woodland, and M A. Blackman. 2000. Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J Immunol. 165: 1074–1081
   PubMed Web of Science ®Google Scholar
• Hochreiter, R., C. Ptaschinski, S. L. Kunkel, and R. Rochford. 2007. Murine gammaherpesvirus-68 productively infects immature dendritic cells and blocks maturation. J Gen Virol. 88: 1896–1905
   PubMed Web of Science ®Google Scholar
• Usherwood, E. J., D. J. Roy, K. Ward, S. L. Surman, B. M. Dutia, M. A. Blackman, J. P. Stewart, and D. L. Woodland. 2000. Control of gammaherpesvirus latency by latent antigen-specific CD8(+) T cells. J Exp Med. 192: 943–952
   PubMed Web of Science ®Google Scholar
• Tripp, R. A., A. M. Hamilton-Easton, R. D. Cardin, P. Nguyen, F. G. Behm, D. L. Woodland, P. C. Doherty, and M. A. Blackman. 1997. Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: role for a viral superantigen? J Exp Med. 185: 1641–1650
   PubMed Web of Science ®Google Scholar
• Elsawa, S. F., and K. L. Bost. 2004. Murine gamma-herpesvirus-68-induced IL-12 contributes to the control of latent viral burden, but also contributes to viral-mediated leukocytosis. J Immunol. 172: 516–524
   PubMed Web of Science ®Google Scholar
• Gasper-Smith, N., I. Marriott, and K. L. Bost. 2006. Murine gamma-herpesvirus 68 limits naturally occurring CD4 + CD25+ T regulatory cell activity following infection. J Immunol. 177: 4670–4678
   PubMed Web of Science ®Google Scholar
• Gasper-Smith, N., S. Singh, and K. L. Bost. 2006. Limited IL-6 production following infection with murine gammaherpesvirus 68. Arch Virol. 151: 1423–1429
   PubMed Web of Science ®Google Scholar
• Chauhan, V. S., S. R. Furr, D. G. Sterka, Jr., D. A. Nelson, M. Moerdyk-Schauwecker, I. Marriott, and V. Z. Grdzelishvili. 2010. Vesicular stomatitis virus infects resident cells of the central nervous system and induces replication-dependent inflammatory responses. Virology. 400: 187–196
   PubMed Web of Science ®Google Scholar
• Furr, S. R., V. S. Chauhan, M. J. Moerdyk-Schauwecker, and I. Marriott. 2011. A role for DNA-dependent activator of interferon regulatory factor in the recognition of herpes simplex virus type 1 by glial cells. J Neuroinflam. 8: 99
   PubMed Web of Science ®Google Scholar
• Chauhan, V. S., D. G. SterkaJr., S. R. Furr, A. B. Young, and I. Marriott. 2009. NOD2 plays an important role in the inflammatory responses of microglia and astrocytes to bacterial CNS pathogens. Glia. 57: 414–423
   PubMed Web of Science ®Google Scholar
• Gulbahar, M. Y., Y. B. Kabak, M. O. Karayigit, M. Yarim, T. Guvenc, and U. Parlak. 2011. The expressions of HSP70 and alphaB-crystallin in myocarditis associated with foot-and-mouth disease virus in lambs. J Vet Sci. 12: 65–73
   PubMed Web of Science ®Google Scholar
• Whiston, E. A., N. Sugi, M. C. Kamradt, C. Sack, S. R. Heimer, M. Engelbert, E. F. Wawrousek, et al. 2008. alphaB-crystallin protects retinal tissue during Staphylococcus aureus-induced endophthalmitis. Infect Immun. 76: 1781–1790
   PubMed Web of Science ®Google Scholar
• Rochford, R., M. L. Lutzke, R. S. Alfinito, A. Clavo, and R. D. Cardin. 2001. Kinetics of murine gammaherpesvirus 68 gene expression following infection of murine cells in culture and in mice. J Virol. 75: 4955–4963
   PubMed Web of Science ®Google Scholar
• Nelson, D. A., M. D. Tolbert, M. G. Clemens, and K. L. Bost. 2010. Interleukin-27 expression following infection with the murine gammaherpesvirus 68. Cytokine. 51: 184–194
   PubMed Web of Science ®Google Scholar
• Chou, Y. K., G. G. Burrows, D. LaTocha, C. Wang, S. Subramanian, D. N. Bourdette, and A. A. Vandenbark. 2004. CD4 T-cell epitopes of human alpha B-crystalline. J Neurosci Res. 75: 516–523
   PubMed Web of Science ®Google Scholar
• Saez-Torres, I., L. Brieva, C. Espejo, M. A. Barrau, X. Montalban, and E. M. Martinez-Caceres. 2002. Specific proliferation towards myelin antigens in patients with multiple sclerosis during a relapse. Autoimmunity. 35: 45–50
   PubMed Web of Science ®Google Scholar
• Vojdani, A., E. Vojdani, and E. Cooper. 2003. Antibodies to myelin basic protein, myelin oligodendrocytes peptides, alpha-beta-crystallin, lymphocyte activation and cytokine production in patients with multiple sclerosis. J Intern Med. 254: 363–374
   PubMed Web of Science ®Google Scholar
• Holman, D. W., R. S. Klein, and R. M. Ransohoff. 2011. The blood-brain barrier, chemokines and multiple sclerosis. Biochim Biophys Acta. 1812: 220–230
   PubMed Web of Science ®Google Scholar
• Romi, F., G. Helgeland, and N. E. Gilhus. 2011. Heat-shock proteins in clinical neurology. Eur Neurol. 66: 65–69
   PubMed Web of Science ®Google Scholar
• de Thonel, A., A. Le Mouel, and V. Mezger. 2012. Transcriptional regulation of small HSP-HSF1 and beyond. Int J Biochem Cell Biol. 44: 1593–1612
   PubMed Web of Science ®Google Scholar
• Cohen, J. I. 2000. Epstein–Barr virus infection. N Engl J Med. 343: 481–492
   PubMed Web of Science ®Google Scholar
• Ascherio, A., and K. L. Munger. 2010. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Epstein–Barr virus and multiple sclerosis: epidemiological evidence. Clin Exp Immunol. 160: 120–124
   PubMed Web of Science ®Google Scholar
• Owens, G. P., and J. L. Bennett. 2012. Trigger, pathogen, or bystander: the complex nexus linking Epstein–Barr virus and multiple sclerosis. Mult Scler. 18: 1204–1208
   PubMed Web of Science ®Google Scholar
• Pender, M. P. 2011. The essential role of Epstein–Barr virus in the pathogenesis of multiple sclerosis. Neuroscientist. 17: 351–367
   PubMed Web of Science ®Google Scholar
• Tselis, A. 2012. Epstein–Barr virus cause of multiple sclerosis. Curr Opin Rheumatol. 24: 424–428
   PubMed Web of Science ®Google Scholar
• Virtanen, J. O., and S. Jacobson. 2012. Viruses and multiple sclerosis. CNS Neurol Disord Drug Targets. 11: 528–544
   PubMed Web of Science ®Google Scholar
• Peacock, J. W., S. F. Elsawa, C. C. Petty, W. F. Hickey, and K. L. Bost. 2003. Exacerbation of experimental autoimmune encephalomyelitis in rodents infected with murine gammaherpesvirus-68. Eur J Immunol. 33: 1849–1858
   PubMed Web of Science ®Google Scholar
• Peacock, J. W., and K. L. Bost. 2001. Murine gammaherpesvirus-68-induced interleukin-10 increases viral burden, but limits virus-induced splenomegaly and leukocytosis. Immunology. 104: 109–117
   PubMed Web of Science ®Google Scholar
• Chauhan, V. S., D. A. Nelson, L. Das Roy, P. Mukherjee, and K. L. Bost. 2012. Exacerbated metastatic disease in a mouse mammary tumor model following latent gammaherpesvirus infection. Infect Agent Cancer. 7: 11
   PubMed Web of Science ®Google Scholar
• Nelson, D. A., C. C. Petty, and K. L. Bost. 2009. Infection with murine gammaherpesvirus 68 exacerbates inflammatory bowel disease in IL-10-deficient mice. Inflamm Res. 58: 881–889
   PubMed Web of Science ®Google Scholar
• Nikolich-Zugich, J. 2008. Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections. Nat Rev Immunol. 8: 512–522
   PubMed Web of Science ®Google Scholar
• Selin, L. K., M. F. Wlodarczyk, A. R. Kraft, S. Nie, L. L. Kenney, R. Puzone, and F. Celada. 2011. Heterologous immunity: immunopathology, autoimmunity and protection during viral infections. Autoimmunity. 44: 328–347
   PubMed Web of Science ®Google Scholar
• Compston, L. I., F. Sarkobie, C. Li, D. Candotti, O. Opare-Sem, and J. P. Allain. 2008. Multiplex real-time PCR for the detection and quantification of latent and persistent viral genomes in cellular or plasma blood fractions. J Virol Meth. 151: 47–54
   PubMed Web of Science ®Google Scholar
• Gulley, M. L., and W. Tang. 2010. Using Epstein–Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder. Clin Microbiol Rev. 23: 350–366
   PubMed Web of Science ®Google Scholar
• Kimura, H., Y. Ito, R. Suzuki, and Y. Nishiyama. 2008. Measuring Epstein–Barr virus (EBV) load: the significance and application for each EBV-associated disease. Rev Med Virol. 18: 305–319
   PubMed Web of Science ®Google Scholar
• Li, L., A. Chaudhuri, L. A. Weintraub, F. Hsieh, S. Shah, S. Alexander, O. Salvatierra, Jr.and M. M. Sarwal. 2007. Subclinical cytomegalovirus and Epstein–Barr virus viremia are associated with adverse outcomes in pediatric renal transplantation. Pediatr Transplant. 11: 187–195
   PubMed Web of Science ®Google Scholar
• Niller, H. H., H. Wolf, and J. Minarovits. 2008. Regulation and dysregulation of Epstein–Barr virus latency: implications for the development of autoimmune diseases. Autoimmunity. 41: 298–328
   PubMed Web of Science ®Google Scholar